tiprankstipranks
Trending News
More News >
Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE
US Market

Sorrento Therapeutics (SRNE) Cash flow

Compare
5,243 Followers

Sorrento Therapeutics Cash Flow

SRNE's free cash flow for Q2 2023 was $-55.80M. For the 2023 fiscal year, SRNE's free cash flow was decreased by $-16.82M and operating cash flow was $-55.66M. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -293.86M$ -281.82M$ -159.54M$ -173.00M$ -111.77M
Investing Cash Flow
$ -28.52M$ 79.85M$ -39.92M$ -38.17M$ -21.20M
Financing Cash Flow
$ 311.72M$ 181.33M$ 174.24M$ 78.89M$ 326.00M
End Cash Position
$ 23.63M$ 36.66M$ 56.46M$ 80.77M$ 168.33M
Free Cash Flow
$ -307.51M$ -290.69M$ -197.12M$ -184.44M$ -132.96M
Currency in USD

Sorrento Therapeutics Cash Flow